SORRENTO THERAPEUTICS INC
SRNE Real Time Price USDRecent trades of SRNE by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SRNE's directors and management
Government lobbying spending instances
-
$50,000 Jan 20, 2023 Issue: Health Issues
-
$150,000 Jan 09, 2023 Issue: Consumer Issues/Safety/Products Pharmacy
-
$50,000 Oct 20, 2022 Issue: Health Issues
-
$150,000 Oct 14, 2022 Issue: Consumer Issues/Safety/Products Pharmacy
-
$10,000 Oct 11, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$50,000 Jul 20, 2022 Issue: Health Issues
-
$150,000 Jun 20, 2022 Issue: Pharmacy
-
$50,000 Apr 20, 2022 Issue: Health Issues
-
$150,000 Apr 06, 2022 Issue: Pharmacy
-
$50,000 Jan 20, 2022 Issue: Health Issues
-
$150,000 Jan 10, 2022 Issue: Pharmacy
-
$10,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 20, 2021 Issue: Health Issues
-
$50,000 Oct 13, 2021 Issue: Health Issues Medicare/Medicaid
-
$110,000 Oct 13, 2021 Issue: Medicare/Medicaid Health Issues
-
$150,000 Oct 08, 2021 Issue: Pharmacy
-
$50,000 Jul 20, 2021 Issue: Health Issues
-
$130,000 Jul 06, 2021 Issue: Pharmacy
-
$10,000 Apr 20, 2021 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs
-
$50,000 Apr 20, 2021 Issue: Health Issues
-
$10,000 Apr 14, 2021 Issue: Medicare/Medicaid Health Issues
-
$20,000 Apr 09, 2021 Issue: Medicare/Medicaid Health Issues
-
$150,000 Apr 07, 2021 Issue: Pharmacy
-
$50,000 Jan 20, 2021 Issue: Health Issues
-
$150,000 Jan 19, 2021 Issue: Pharmacy
-
$90,000 Jan 14, 2021 Issue: Health Issues Medicare/Medicaid
-
$50,000 Jan 14, 2021 Issue: Medicare/Medicaid Health Issues
-
$45,000 Oct 20, 2020 Issue: Health Issues
-
$50,000 Oct 09, 2020 Issue: Health Issues Medicare/Medicaid
-
$20,000 Oct 09, 2020 Issue: Health Issues Medicare/Medicaid
-
$30,000 Jul 20, 2020 Issue: Health Issues
-
$30,000 Jul 13, 2020 Issue: Medicare/Medicaid Health Issues
-
$60,000 Jul 13, 2020 Issue: Health Issues Medicare/Medicaid
-
$20,000 Apr 17, 2020 Issue: None
-
$10,000 Apr 10, 2020 Issue: Health Issues Medicare/Medicaid
-
$20,000 Apr 10, 2020 Issue: Health Issues Medicare/Medicaid
-
$30,000 Apr 10, 2020 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jan 15, 2020 Issue: Health Issues Medicare/Medicaid
-
$10,000 Oct 15, 2019 Issue: Medicare/Medicaid Health Issues
-
$20,000 Oct 15, 2019 Issue: Medicare/Medicaid Health Issues
-
$10,000 Jul 24, 2019 Issue: Medicare/Medicaid Health Issues
-
$20,000 Jul 16, 2019 Issue: Health Issues Medicare/Medicaid
-
$7,500 Jan 12, 2018 Issue: Health Issues Medicare/Medicaid
-
$30,000 Oct 18, 2017 Issue: Health Issues
-
$7,500 Oct 13, 2017 Issue: Health Issues
-
$7,500 Jul 03, 2017 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SRNE in WallStreetBets Daily Discussion
Recent insights relating to SRNE
Recent picks made for SRNE stock on CNBC
ETFs with the largest estimated holdings in SRNE
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SRNE Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.